https://www.selleckchem.com/pr....oducts/pluronic-f-68
Device success was achieved in 45 (97.8%) patients with reduction of diameter stenosis from 80% to 5.2% with an acute gain of 2.5 mm. Clinical success was demonstrated in 95.6% of cases. During the 30-day follow-up, one sudden death was recorded, regarded as probable subacute stent thrombosis. During 6-month follow up one target lesion and target vessel revascularizations occurred. The rate of MACE after 6month was 6.2%. S-IVL appears to be a safe and effective treatment modality in coronary calcium modification to optimize stent
כמו
תגובה
לַחֲלוֹק
